CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,086 | $586.37 | $1.8M | 325,509 |
| 2026-10-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −986 | $587.27 | $579K | 324,523 |
| 2026-10-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $588.39 | $47K | 324,443 |
| 2026-10-28 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 138,410 | ||
| 2026-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −89 | $582.66 | $52K | 333,854 |
| 2026-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −807 | $583.94 | $471K | 333,047 |
| 2026-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,417 | $584.83 | $829K | 331,630 |
| 2026-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −470 | $585.72 | $275K | 331,160 |
| 2026-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,417 | $586.93 | $832K | 329,743 |
| 2026-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,320 | $587.88 | $776K | 328,423 |
| 2026-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,597 | $588.95 | $941K | 326,826 |
| 2026-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,003 | $589.98 | $592K | 325,823 |
| 2026-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −700 | $590.99 | $414K | 325,123 |
| 2026-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −600 | $592.05 | $355K | 324,523 |
| 2026-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $592.84 | $47K | 324,443 |
| 2026-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 147,910 | ||
| 2026-10-26 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −600 | $585.71 | $351K | 333,343 |
| 2026-10-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,492 | $586.54 | $875K | 331,851 |
Page 11 of 64 · 1,267 trades